Skip to main content

Pierce Inks Deal with GenTel to Distribute Slides, Use Tech for Protein Arrays

NEW YORK, Oct. 27 (GenomeWeb News) - Pierce Biotechnology, a unit of Fisher Biosciences, will distribute GenTel BioSurfaces's thin-film nitrocellulose slides and has also licensed GenTel technology to develop its onw protein arrays, the companies said yesterday.


GenTel's PATH brand slides are specifically designed for protein-array applications and are 50 times thinner than conventional nitrocellulose slides, GenTel said. The slides are also compatible with Pierce chemiluminescent-detection systems.


Pierce will use GenTel's technology to build on its SearchLight multiplex protein-profiling system. Microarray systems using GenTel's technology will allow researchers to measure the expression of up to 25 proteins in one experiment, the company said.


Additional details were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.